Statins May Lower Dementia Risk in Patients With AF on Oral Anticoagulants
A study was conducted to determine if statin therapy affects risk for dementia in patients with atrial fibrillation receiving oral anticoagulation.
A study was conducted to determine if statin therapy affects risk for dementia in patients with atrial fibrillation receiving oral anticoagulation.
A study was conducted to determine the effect of oral anticoagulant therapy on risk for dementia in patients with nonvalvular atrial fibrillation.
Researchers assessed the relationship between oral anticoagulation for patients with COVID-19 and AF and incidence of in-hospital thrombotic events and death.
Researchers sought to determine the amount of residual anticoagulation from apixaban in patients who discontinued the medication prior to surgery
Researchers investigated racial and ethnic disparities in anticoagulation initiation in patients dually enrolled in the Veterans Health Administration and Medicare.
In expanded research, investigators studied the effects of therapeutic and prophylactic anticoagulation treatment in hospitalized patients with COVID-19.
This study has observed that if atrial fibrillation episodes are brief, the risk of stroke is low.